Related Experiment Video
Updated: Mar 30, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Coronary Artery Disease and Diabetes Mellitus
Doron Aronson1, Elazer R Edelman2
1Department of Cardiology, Rambam Medical Center, Technion, Israel Institute of Technology, P.O.B 9602, Haifa 31096, Israel.
Insights
Diabetes mellitus (DM) increases cardiovascular disease risk. For multivessel coronary disease, coronary artery bypass grafting is superior to percutaneous coronary intervention in patients with DM, requiring a heart team approach.
Area of Science:
- Cardiology
- Endocrinology
- Medical Therapy
Background:
- Diabetes mellitus (DM) is a significant risk factor for cardiovascular disease (CVD).
- Optimal glycemic control alone does not effectively reduce cardiovascular events in diabetic patients.
- Revascularization strategies for coronary artery disease (CAD) in DM require careful consideration.
Purpose of the Study:
- To review current evidence on medical therapies for DM and CVD.
- To evaluate the effectiveness of revascularization strategies in diabetic patients with CAD.
- To highlight the importance of a multidisciplinary approach in selecting optimal treatment.
Main Methods:
- Systematic review of randomized trials and current evidence.
- Analysis of comparative effectiveness of medical therapy versus revascularization.
- Evaluation of different revascularization techniques (CABG vs. PCI) in DM patients.
Main Results:
- Near-normal glycemic control does not decrease cardiovascular events.
- For 1- or 2-vessel CAD, revascularization offers minimal benefit over optimal medical therapy.
- Coronary artery bypass grafting (CABG) is superior to multivessel percutaneous coronary intervention (PCI) for multivessel CAD in patients with DM.
Conclusions:
- Treatment decisions for CAD in diabetic patients necessitate a multidisciplinary 'heart team' approach.
- CABG demonstrates superior outcomes compared to PCI for multivessel disease in DM.
- Personalized medical therapy and strategic revascularization are crucial for managing CVD in diabetes mellitus.
Abstract:
Diabetes mellitus (DM) is a major risk factor for cardiovascular disease. Near-normal glycemic control does not reduce cardiovascular events. For many patients with 1- or 2-vessel coronary artery disease, there is little benefit from any revascularization procedure over optimal medical therapy. For multivessel coronary disease, randomized trials demonstrated the superiority of coronary artery bypass grafting over multivessel percutaneous coronary intervention in patients with treated DM. However, selection of the optimal myocardial revascularization strategy requires a multidisciplinary team approach ('heart team'). This review summarizes the current evidence regarding the effectiveness of various medical therapies and revascularization strategies in patients with DM.
More Related Videos
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Coronary Artery Disease IV: Preventive Measures